Ramucirumab (IMC 1121B, Cyramza) and Bevacizumab (Avastin). Epidermal Growth Factor Receptor (EGFR) pathway inhibitors. Panitumumab (Vectibix) and Cetuximab (Erbitux). We had Regorafenib (Stivarga) approved. A new colon cancer treatment medication TAS-102 (Lonsurf) is now approved. “I think we are getting access to new effective treatments for colon cancer that we didn’t have in the past.”
Home » Expert Centers » Colorectal Cancer » New targeted chemotherapy of colon cancer. TAS-102, Stivarga, Cyramza. 8